Asahi Kasei Corporation

RECLASTZoledronic Acid

SHARE

Reclast® is a bisphosphonate agent that suppresses bone resorption, for the treatment of osteoporosis. Reclast® is capable of a year-long treatment with once-a-year intravenous infusion. Reclast® is a registered trademark of Novartis.